The data obtained in this study reveal that RAC1B effectively inhibits TGFβ1-dependent cell motility of mesenchymal subtype carcinoma cells by promoting protein expression of the inhibitory Smad, SMAD7, via intermittent transcriptional induction of the deubiquitinating enzyme, USP26. The gene discussed is SMAD7; the disease is carcinoma.